Y 445.17 Alleghany Corp $Y Hit a 52 week high of 448.37

New Post Public Reply Private Reply Replies (0) Message Board

Nov 5, 2014 at 9:19 AM

Y 445.17 Alleghany Corp $Y Hit a 52 week high of 448.37 Closing the day 11/04/14 at 445.17 -3.20 -0.71% With a day low of 441.85 and a total volume of 47,300.

Y Recent Posts: http://investorshangout.com/Alleghany-Corp-Y-53165/

Y Alleghany Corp Recent Headline News

Alleghany Q3 Earnings Beat on Solid Underwriting Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 9:20AM CST
Alleghany Corporation (Y) reported net earnings of $11.40 per share for the third quarter of 2014, outperforming the Zacks Consensus Estimate of $7.82 by 45.8%
RE: 171.55 (+0.84), CB: 99.60 (+0.70), Y: 445.17 (-3.20), WRB: 51.61 (+0.19)

Alleghany posts 3Q profit
Automated Insights - Mon Nov 03, 6:45PM CST
NEW YORK (AP) _ Alleghany Corp. (Y) on Monday reported profit of $186.3 million, or $11.40 per share, in its third quarter.
Y: 445.17 (-3.20)

W.R. Berkley Hits 52-Week High on Strong Q3 Performance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 3:53PM CST
Shares of W.R. Berkley Corp. (WRB) hits 52-week high on robust third quarter earnings.
AFSI: 49.88 (+3.18), ENH: 57.56 (-0.92), Y: 445.17 (-3.20), WRB: 51.61 (+0.19)

Alleghany Corporation Reports 2014 Third Quarter Results -- Notice
PR Newswire - Mon Nov 03, 3:14PM CST
Alleghany Corporation (NYSE: Y) today reported its financial results for the three and nine months ended September 30, 2014. A complete, full-text news release for Alleghany's 2014 third quarter results is available on Alleghany's website at www.alleghany.com and is also contained in a Current Report on Form 8-K that has been filed with the U.S. Securities and Exchange Commission (the "SEC"

and is available on the SEC's website at www.sec.gov. In conjunction with the release, Alleghany has also posted its financial supplement to the company's web-site at www.alleghany.com.
Y: 445.17 (-3.20)

Olshan Recognized as First Tier "Best Law Firm" in New York for Securities and Capital Markets and Real Estate Law by U.S. News-Best Lawyers
PR Newswire - Mon Nov 03, 6:30AM CST
Olshan Frome Wolosky LLP today announced that it has been ranked "Tier 1" in the New York City Metropolitan area for Securities and Capital Markets and Real Estate Law by U.S. News-Best Lawyers® "Best Law Firms" 2015, and has been ranked "Tier 2" Nationally for both the Securities and Capital Markets and Real Estate practices.
JASN: 8.84 (unch), Y: 445.17 (-3.20)

Alleghany Capital Corporation Announces Two Acquisitions By Kentucky Trailer
PR Newswire - Tue Oct 28, 8:27AM CDT
Alleghany Capital Corporation ("ACC"

, a wholly-owned subsidiary of Alleghany Corporation, today announced that its subsidiary, R.C. Tway Company, LLC ("Kentucky Trailer"

, a leading manufacturer of custom trailers and truck bodies, has acquired Advanced Mobility & Shelter Technologies, LLC ("Advanced Mobility"

. Advanced Mobility is a designer and builder of custom trailers and specialty vehicles primarily for the mobile medical and television broadcast markets. In a separate transaction, Kentucky Trailer also acquired a complementary specialty vehicle field service operation.
Y: 445.17 (-3.20)

W.R. Berkley Beats Earnings, Revenues on High Premiums - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 9:30AM CDT
W.R. Berkley Corporation (WRB) reported third-quarter 2014 operating income of $1.06 per share, outperforming the Zacks Consensus Estimate by 16.5%
AFSI: 49.88 (+3.18), Y: 445.17 (-3.20), AWH: 37.39 (+0.04), WRB: 51.61 (+0.19)

Chubb Beats Q3 Earnings on Low CAT Loss; Raises Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 9:20AM CDT
The Chubb Corporation (CB) reported third-quarter operating income of $2.17 per share, which surpassed the Zacks Consensus Estimate by 11.3% and improved 5% year over year.
AFSI: 49.88 (+3.18), CB: 99.60 (+0.70), Y: 445.17 (-3.20), AWH: 37.39 (+0.04)

Everest Re Q3 Earnings Beat Estimates, Top Line Grows - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 8:00AM CDT
Everest Re (RE) posts solid third quarter results, revenues grow.
RE: 171.55 (+0.84), AFSI: 49.88 (+3.18), Y: 445.17 (-3.20), AWH: 37.39 (+0.04)

AmTrust Financial Hits 52-Week High on Positive Tidings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 12:30PM CDT
On Oct 21, 2014, AmTrust Financial Services, Inc. (AFSI) scaled a 52-week high of $50.00 on the back of a series of positive tidings.
AFSI: 49.88 (+3.18), ENH: 57.56 (-0.92), Y: 445.17 (-3.20), TRV: 101.13 (+1.18)

Apogee, Actuant, Allied World Assurance,Alleghany andHCI Group highlighted as Zacks Bull and Bear of the Day
PR Newswire - Wed Oct 22, 8:30AM CDT
Zacks Equity Research highlights Apogee (Nasdaq:APOG-Free Report) as the Bull of the Day and Actuant (NYSE:ATU-Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis onAllied World Assurance Company Holdings, AG (NYSE:AWH-Free Report), Alleghany Corp. (NYSE:Y-Free Report) and HCI Group, Inc. (NYSE:HCI-Free Report).
Y: 445.17 (-3.20)

Is Allied World (AWH) Worth Adding to Your Portfolio? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 21, 5:15PM CDT
On Oct 21, 2014, Zacks Investment Research upgraded Allied World Assurance Company Holdings, AG (AWH) to a Zacks Rank #1 (Strong Buy).
HCI: 49.29 (-0.59), ENH: 57.56 (-0.92), Y: 445.17 (-3.20), AWH: 37.39 (+0.04)

Atlas Financial Inks Global Liberty Deal to Boost Position - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 20, 6:15PM CDT
Atlas Financial Holdings, Inc. (AFH) has inked a deal to acquire Global Liberty Insurance Company and its affiliated underwriting and premium finance companies.
RLI: 49.61 (+0.35), ENH: 57.56 (-0.92), Y: 445.17 (-3.20)

Atlas Financial Holdings (AFH) Rises: Stock Up 7.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 20, 8:04AM CDT
Atlas Financial Holdings, Inc. (AFH) was a big mover last session, as the company saw its shares rise over 7% on the day.
HCI: 49.29 (-0.59), AFH: 14.59 (+0.02), ENH: 57.56 (-0.92), Y: 445.17 (-3.20)

RLI Corp Q3 Earnings Beat, Down Y/Y on Higher Expense - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 16, 8:10AM CDT
RLI Corp.'s (RLI) third-quarter operating earnings of 68 cents per share beat the Zacks Consensus Estimate by 13% but lagged year over year on higher expenses.
AHL: 43.73 (+0.12), RLI: 49.61 (+0.35), ENH: 57.56 (-0.92), Y: 445.17 (-3.20)

Is White Mountains (WTM) Worth Adding to Your Portfolio? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 12:40PM CDT
On Oct 15, 2014, Zacks Investment Research upgraded White Mountains Insurance Group, Ltd. (WTM) to a Zacks Rank #1 (Strong Buy).
AHL: 43.73 (+0.12), WTM: 618.62 (-5.10), Y: 445.17 (-3.20), OB: 16.07 (+0.06)

ProAssurance's Acquisitions, Capital Activity Look Good - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 12:10PM CDT
On Oct 10, 2014, we issued an updated research report on ProAssurance Corporation (PRA).
AHL: 43.73 (+0.12), AGII: 55.32 (+0.18), PRA: 46.74 (+0.19), Y: 445.17 (-3.20)

Donegal Group (DGICA) Gains on A.M. Best's Rating Action - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 6:00PM CDT
Shares of Donegal Group Inc. (DGICA) increased 1.4% over the last trading session to close at $15.79 after affirmation of the company's ratings by A. M. Best Company.
AHL: 43.73 (+0.12), AFSI: 49.88 (+3.18), DGICA: 15.85 (+0.09), Y: 445.17 (-3.20)

Should AmTrust Financial (AFSI) be in Your Portfolio Now? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 1:40PM CDT
On Oct 9, Zacks Investment Research upgraded AmTrust Financial Services, Inc. (AFSI) to a Zacks Rank #1 (Strong Buy).
AHL: 43.73 (+0.12), AGII: 55.32 (+0.18), AFSI: 49.88 (+3.18), Y: 445.17 (-3.20)

Zacks Rank #1 Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 08, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
CYCC: 3.18 (unch), CMG: 647.68 (+9.15), Y: 445.17 (-3.20), CVRR: 24.20 (-0.12), ALGT: 137.31 (+2.72)

Alleghany Corp. (Y) Stock Research Links

Y Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Spooky Dining at CARNE: A Halloween Hit in Oxnard

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Fluence Energy Hits Legal Snag: Investors Called to Act

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Community in Shock After Fatal Bakersfield Shooting

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...